WDR90: A Potential Drug Target and Biomarker (G197335)

Target Name: WDR90

NCBI ID: G197335

WDR90

WDR90: A Potential Drug Target and Biomarker

Wdr90 is a gene that encodes a protein known as WDR90. WDR90 is a 90 amino acid long protein that is expressed in various tissues and cells throughout the body. It is involved in the development and maintenance of tissues, including the brain, eye, and heart. WDR90 has been identified as a potential drug target and biomarker due to its unique structure and function<1,2>.

The WDR90 gene was first identified in 2008 by researchers at the University of California, San Diego. The gene was found to be expressed in various tissues and cells, including the brain, eye, and heart. The WDR90 protein is composed of 90 amino acids and has a predicted localization in the cell membrane<3>.

WDR90 has been shown to play a role in several important cellular processes, including cell adhesion, migration, and invasion. It is involved in the development and maintenance of tissues and has been shown to contribute to the development of various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

One of the key functions of WDR90 is its role in cell adhesion and migration. It is involved in the formation of tight junctions, which are specialized barriers that maintain tissue structure and prevent fluid and solute from passing through the membrane. WDR90 is also involved in the regulation of cell migration, which is essential for the development and maintenance of tissues and organs.

WDR90 has also been shown to be involved in the regulation of cell survival and apoptosis. It is involved in the production of reactive oxygen species (ROS), which can damage cellular components and contribute to the development of oxidative stress-induced diseases. WDR90 also plays a role in the regulation of cell apoptosis, which is a natural mechanism for cell death that helps to remove damaged or dysfunctional cells from the body.

In addition to its role in cell biology, WDR90 has also been shown to be involved in the development and maintenance of tissues and organs. It is involved in the formation of tissues and organs, including the brain and eye, and has been shown to contribute to the development and maintenance of these tissues.

WDR90 has also been identified as a potential drug target due to its unique structure and function. Its expression in various tissues and cells makes it a potential target for small molecules, antibodies, or other therapeutic agents that can modulate its activity. Additionally, its role in several important cellular processes makes it a potential biomarker for a variety of diseases.

In conclusion, WDR90 is a gene that encodes a protein involved in the development and maintenance of tissues and organs. Its unique structure and function make it a potential drug target and biomarker. Further research is needed to fully understand its role in cellular biology and its potential as a therapeutic agent.

Protein Name: WD Repeat Domain 90

Functions: Required for efficient primary cilium formation

The "WDR90 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about WDR90 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets